Browse diseases

…y suggests that early belimumab use may rapidly delay damage in SLE. Future research is needed to confirm results and inform clinic…

…for refractory thrombocytopenia.Conclusions Thrombocytopenia in SLE remains relatively common. Its reported association with severe…

…erative diseases.Results The patient was diagnosed with SLE and Sjögren’s syndrome in October 2024, during his first admission based on the presen…

…with AKI (Cr 3.09), anasarca, HTN, hematuria & 1 gr proteinuria.SLE Dx was at the age of 27, based on +ANA with nucleolar pattern, …

…ves To define a fit-for-purpose clinical outcome assessment for lupus arthritis, with thresholds for entry and improvement, which will form par…

…Objectives Systemic Lupus Erythematosus (SLE) is an autoimmune disease driven by B-cell dysregulation. …

…s To characterize patterns and variability in the management of systemic lupus erythematosus (SLE), including the implementation of a treat to target (T2T) …

…points (p=0.0018). PhGA was not significantly different between SLE and RA patients in low disease activity or remission, and only …

…jectives To evaluate the serological evolution of patients with systemic lupus erythematosus (SLE), focusing on the appearance or modification of existing a…

…Objectives Lupus nephritis (LN) presents differently across geographic regions, with highe…

…ars, analyzing safety and efficacy parameters.Results Among 277 SLE patients in follow-up, 7 were treated with BEL for more than 10…

…ne therapy in patients with AIHAConclusions In the treatment of SLE-associated AIHA, early response to CS therapy was favorable, and the early use …